• 1
    Haslewood GAD. Hyocholic acid, a trihydroxy bile acid from pig bile. Bio–chem J 1954; 56: 3839.
  • 2
    Lin H, Rubinstein N, Holmes WL. A study on the effect of D- and L-triiodothyronine on bile acid excretion of rats. J Lipid Res 1963; 4: 6367.
  • 3
    Makita M, Wells WW. Quantitative analysis of fecal bile acids by gas-liquid chromatography. Anal Biochem 1963; 5: 523530.
  • 4
    Almé B, Bremmelgaard A, Sjövall J, Thomasse P. Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatography-mass spectrometry. J Lipid Res 1977; 18: 339362.
  • 5
    Summerfield JA, Billing BH, Shackleton CHL. Identification of bile acids in the serum and urine in cholestasis. Evidence for 6-alpha hydroxylation of bile acids in man. Biochem J 1976; 154: 507516.
  • 6
    Bremmelgaard A, Sjövall J. Hydroxylation of cholic, chenodeoxycholic, and deoxycholic acids in patients with intrahepatic cholestasis. J Lipid Res 1980; 21: 10271081.
  • 7
    Hall SR, Maslen EN, Cooper A. The crystal and molecular structure of 3,6α-dihydroxy-5β cholan-24-oic acid. Acta Crystallogr 1974; B30: 15511557.
  • 8
    Armstrong MJ, Carey MC. The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar-solubilizing capacities. J Lipid Res 1982; 23: 7080.
  • 9
    Nakagawa S, Makino I, Ishizaki T, Dohi I. Dissolution of cholesterol gallstones by ursodeoxycholic acid. Lancet 1977; 2: 367369.
  • 10
    Bachrach WH, Hofmann AF. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Dig Dis Sci 1982; 27: 737761, 833–856.
  • 11
    Maton PN, Murphy GM, Dowling RH. Ursodeoxycholic acid treatment of gallstones. Dose response study and possible mechanism of action. Lancet 1977; 2: 12971301.
  • 12
    Stiehl A, Czygan P, Kommerell B, Weis HG, Holtermuller KH. Ursodeoxycholic acid versus chenodeoxycholic acid: comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones. Gastroenterology 1978; 75: 10161020.
  • 13
    Leiss O, Bosch T, Von Bergman K. Effects of bile acid feeding on lipoprotein concentration, change in cholesterol synthesis and biliary lipid secretion in patients with radiolucent gallstones. In: PaumgartnerG, StiehlA, GerokW, eds. Bile Acids and Lipids. London: MTP, 1981: 247253.
  • 14
    Nilsell K, Angelin B, Leijd B, Einarsson K. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis. Gastroenterology 1983; 85: 12481256.
  • 15
    Leuschner U, Leuschner M, Sierratzki J, Kurtz W, Hübner K. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study. Dig Dis Sci 1985; 30: 642649.
  • 16
    Poupon R, Poupon RE, Calmus J, Chrétien Y, Ballet F, Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987; 1: 834836.
  • 17
    De Caestecker JS, Jazrawi RP, Petroni ML, Northfield TC. Ursodeoxycholic acid in chronic liver disease. Gut 1991; 32: 10611065.
  • 18
    Attili AF, Angelico M, Cantafora A, Alvaro D, Capocaccia L. Bile acid induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med Hypotheses 1986; 19: 5769.
  • 19
    Heuman DM. Hepatoprotective properties of ursodeoxycholic acid. Gastroenterology 1993; 104: 18651870.
  • 20
    Dam H, Prange I, Søndergaard E. Alimentary production of gallstones in hamsters. Influence of orally ingested chenodeoxycholic and hyodeoxy-cholic acid on formation of gallstones. Z E mannings wiss 1972; 11: 8094.
  • 21
    Singhal AK, Cohen BI, Finver-Sadowsky J, McSherry CK, Mosbach EH. Role of hydrophilic bile acids and of sterols on cholelithiasis in the hamster. J Lipid Res 1984; 25: 564570.
  • 22
    Cohen BI, Matoba N, Mosbach EH, Ayyad N, Hakam K, Suh SO, McSherry CK. Bile acids substituted in the 6 position prevent cholesterol gallstone formation in the hamster. Gastroenterology 1990; 98: 397405.
  • 23
    Singhal AK, Cohen BI, Mosbach EH, Une M, Stenger RJ, McSherry CK, May-Donath P, Palaia T. Prevention of cholesterol-induced gallstones by hyodeoxycholic acid in the prairie dog. J Lipid Res 1984; 25: 539549.
  • 24
    McSherry CK, Mosbach EH, Cohen BI, Une M, Stenger RJ, Singhal AK. Hyodeoxycholic acid: a new approach to gallstone prevention. Am J Surg 1985; 149: 126132.
  • 25
    Cohen BI, Mosbach EW, McSherry CK, Stenger RJ, Kuroki S, Rzigalinski B. Gallstone prevention in prairie dogs: comparison of chow vs semisynthetic diets. Hepatology 1986; 6: 874880.
  • 26
    Thistle JL, Schoenfield LJ. Induced alterations in composition of bile of persons having cholelithiasis. Gastroenterology 1971; 61: 488493.
  • 27
    Sacquet E, Parquet M, Riottot M, Raizman A, Jarrige P, Huguet C, Infante R. Intestinal absorption, excretion and biotransformation of hyodeoxycholic acid in man. J Lipid Res 1983; 24: 604613.
  • 28
    Hofmann AF, Palmer KA, Yoon YB, Hagey LA, Gurantz D, Huijghebaert S, Converse JL, Cecchetti S, Michelotti E. The biological utility of the bile acid conjugation with glycine and taurine. In: MaternS, GerokW, BockKW, eds. Advances in glucuronide conjugation. Lancaster: MTP, 1984: 245264.
  • 29
    Carey MC. Bile acids and bile salts ionization and solubility properties. Hepatology 1984; 4: 66S71S.
  • 30
    Hepner GW, Sturman JA, Hofmann AF, Thomas PJ. Metabolism of steroid and amino acid moieties of conjugated bile acids in man. III Cholyltaurine (taurocholic acid). J Clin Invest 1973; 52: 433440.
  • 31
    Angelico M, Baiocchi L, Nistri A, Franchitto A, Delia Guardia P, Gaudio E. Effect of taurohyodeoxycholic acid, a hydrophilic bile salt, on bile salt and biliary lipid secretion in the rat. Dig Dis Sci 1994; 39: 23892397.
  • 32
    Angelico M, Mogavero L, Baiocchi L, Nistri A, Gandini C. Dissolution of human cholesterol gallstones in bile salt-lecithin mixtures: effect of bile salt hydrophobicity and various pHs. Scand J Gastroenterol 1995; 30: 11781185.
  • 33
    Salvioli G, Igimi H, Carey MC. Cholesterol gallstone dissolution in bile. Dissolution kinetics of crystalline cholesterol monohydrate by conjugated chenodeoxycholate-lecithin and conjugated ursodeoxycholate-lecithin mixtures: dissimilar phase equilibria and dissolution mechanisms. J Lipid Res 1983; 24: 701720.
  • 34
    Carulli N, Loria P, Bertolotti M, Ponz De Leon M, Menozzi D, Medici G, Piccagli I. Effects of acute changes of bile acid pool composition on biliary lipid secretion. J Clin Invest 1984; 74: 614624.
  • 35
    Loria P, Carulli N, Medici G, Menozzi D, Salvioli G, Bertolotti M, Mon-tanari M. Effect of ursocholic acid on bile lipid secretion and composition. Gastroenterology 1986; 90: 865874.
  • 36
    Talalay P. Enzymatic analysis of steroid hormones. Methods Biochem Anal 1960; 8: 119149.
  • 37
    Abell LL, Brodie BB, Levy BB, Kendall FL. A simplified method for estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 1952; 195: 357366.
  • 38
    Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959; 234: 466468.
  • 39
    Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978; 19: 945955.
  • 40
    Cohen DE, Carey MC. Rapid (1 hour) high-performance gel filtration chromatography resolves coexisting simple micelles, mixed micelles and vesicles in bile. J Lipid Res 1990; 31: 21032112.
  • 41
    Ginanni Corradini S, Arancia G, Calcabrini A, Delia Guardia P, Baiocchi L, Nistri A, Giacomelli L, et al. Lamellar bodies coexist with vesicles and micelles in human gallbladder bile. Ursodeoxycholic acid prevents cholesterol crystal nucleation by increasing biliary lamellae. J Hepatol 1995; 22: 642657.
  • 42
    Lanzini A, Northfield TC. Biliary lipid secretion in man. Eur J Clin Invest 1991; 21: 259272.
  • 43
    Verkade HJ, Vonk RJ, Kuipers F. New insights into the mechanism of bile acid-induced biliary lipid secretion. Hepatology 1995; 21: 11741189.
  • 44
    Cohen DE, Leonard MR, Carey MC. In vitro evidence that phospholipid secretion into bile may be coordinated intracellularly by the combined actions of bile salts and the specific phosphatidylcholine transfer protein of liver. Biochemistry 1994; 33: 99759980.
  • 45
    Berr F, Meier PJ, Stieger B. Evidence for the presence of a phosphatidylcholine translocator in isolated rat liver canalicular plasma membrane vesicles. J Biol Chem 1993; 268: 39763979.
  • 46
    Ou de Elferink RPJ, Ottenhoff R, van Wijland M, Smit JJM, Schinkel AH, Groen AK. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. J Clin Invest 1995; 95: 3138.
  • 47
    Cohen DE, Angelico M, Carey MC. Quasielastic light scattering evidence for vesicular secretion of biliary lipids. Am J Physiol 1989; 257: G1G8.
  • 48
    Sömjen GJ, Marikovsky Y, Wachtel E, Harvey PRC, Rosenberg R, Stras-berg SM, Gilat T. Phospholipid lamellae are cholesterol carriers in human bile. Biochim Biophys Acta 1990; 1042: 2835.
  • 49
    Mizuno S, Tazuma S, Sagawa H, Hatsushika S, Yamashita G, Aihara N, Sasaki H, et al. Non-micellar and non-vesicular discoidal particles in native and supersaturated model bile systems: a key particle dictating cholesterol crystal nucleation [Abstract]. Gastroenterology 1991; 100: A775.
  • 50
    Cohen DE, Kaler EW, Carey MC. Cholesterol carriers in human bile: are “lamellae” involved? Hepatology 1993; 18: 15221531.
  • 51
    Park Y, Igimi H, Carey MC. Dissolution of human cholesterol gallstones in simulated chenodeoxycholate-rich and ursodeoxycholate-rich biles. An in vitro study of dissolution rates and mechanisms. Gastroenterology 1984; 87: 150158.
  • 52
    Stolk MFJ, van de Heijning BJM, van Erpecum KJ, van den Broek AMWC, Renooij W, van Berge–Henegouwen GP. The effect of bile acid hydrophobicity on nucleation of several types of cholesterol crystals from model bile vesicles. J Hepatol 1994; 20: 802810.
  • 53
    van de Heijning BJM, Stolk MFJ, van Erpecum KJ, Renooij W, Groen AK, van Berge-Henegouwen GP. Bile salt induced cholesterol crystal formation from model bile vesicles: a time course study. J Lipid Res 1994; 35: 10021011.
  • 54
    Aldini R, Roda A, Simoni P, Lenzi P, Roda E. Uptake of bile acids by perfused rat liver: evidence of a structure-activity relationship. Hepatology 1989; 10: 840845.
  • 55
    Aldini R, Roda A, Montagnani M, Polimeni C, Lenzi L, Cerré C, Galletti G, Roda E. Hepatic uptake and intestinal absorption of bile acids in the rabbit. Eur J Clin Invest 1994; 24: 691697.
  • 56
    Salvioli G, Lugli R, Pradelli JM, Frignani A, Boccaletti V. Urinary excretion of bile acids during acute administration in man. Eur J Clin Invest 1988; 18: 2228.
  • 57
    Batta AK, Salen G, Shefer S, Tint GS, Dayal B. The effect of taurourso-deoxycholic acid and taurine supplementation on biliary bile acid composition. Hepatology 1982; 2: 811816.
  • 58
    Ellenhorn MJ, Barceloux DG. Anticonvulsiants. In: Medical Toxicology. Chap. 12. Amsterdam, The Netherlands: Elsevier Science, 1988: 229261.
  • 59
    Redinger RN. The effects of phenobarbital on biliary lipid metabolism in cholesterol gallstone subjects. Lipids 1979; 14: 277284.
  • 60
    Fröhling W, Stiehl A, Czygan P, Kommerel B. Induction and activation of rat liver microsomal bile salt glucuronyltransferase. Biochim Biophys Acta 1976; 444: 525530.
  • 61
    Radominska-Pyrek A, Zimniak P, Irshaid YM, Lester R, Tephly TR St, Pyrek J. Glucuronidation of 6α-hydroxy bile acids by human liver micro-somes. J Clin Invest 1987; 80: 234241.
  • 62
    Guicciardi ME, Concari M, Carubbi F, Bozzoli M, Loria P, Bertolotti M, Tagliazucchi M, et al. Hepatoprotective properties of bile acids (BA): effect of taurohyodeoxycholic acid (THDC) on Hep G2 cells [Abstract]. J Hepatol 1994; 21: S143.